Yaohai Biopharmaceutical Co., Ltd. (abbreviatedly called Yaohai Bio-Pharma) was founded in August 2010.
It has served as a CRDMO (Contract, Research, Development, and Manufacturing Organization) specializing in microbial expression systems and offering one-stop solutions, including microbial strain engineering, microbial cell banking, process development, analysis and testing, and large-scale and cGMP-guided manufacturing of clinical samples and commercial products, etc.
Since its establishment, we have been focusing on "recombinant protein, peptide, cytokine, plasmid DNA, single-domain antibody, enzyme, and others" as vaccines or therapeutics for human, veterinary, and pet health management.
Experienced with over 200 projects, our 7500L GMP production platforms and the quality system (QP audit passed and secured ISO triple certification) ensure providing one-stop solutions for a variety of requests.
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
